Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01857011Phase 3Completed
Phase 3, randomised, open-label trial of iron sucrose in iron deficiency anemia (IDA), sponsored by Federal University of São Paulo. Primary endpoint: Hemoglobin at 8 weeks. Started Apr 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01857011.